AON-D-21

N/A

Report date: 2024/06/27 20:00:09
NME

Base Information

Drug NameAON-D-21
Drug Alias NameAON-D-21
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor antagonists
TargetsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsCommunity Acquired Pneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesGermany +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAptarion Biotech AG
China Registration ClassN/A

Develop Information

Active CompaniesAptarion Biotech AG
Inactive CompaniesN/A
Active IndicationsCommunity Acquired Pneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A